WebCardiomyopathy is the most common cardiac toxicity of anthracyclines, but they can often cause primary CTIA, as well as CTIA secondary to cardiomyopathy. Cardiomyopathy associated with anthracyclines is usually dose dependent (5%–8% incidence at 450 mg/m 2 cumulative dose) and not reversible. 8 WebFatal cardiomyopathy developed in two patients receiving cyclophosphamide in preparation for bone marrow transplantation. Both patients had normal EKGs prior to receiving cyclophosphamide in total doses of 168 mg/kg (case 1) and 144 mg/kg (case 2) and subsequently developed loss of voltage and ST-T wave changes.
Cyclophosphamide-Induced Cardiomyopathy: A Case …
WebAug 11, 2024 · It is a chemotherapy drug that works by slowing or stopping cell growth. Cyclophosphamide also works by decreasing your immune system 's response to various diseases. It is used to treat a certain type of kidney disease in children after other treatments have not worked. WebNov 15, 2024 · Takotsubo cardiomyopathy, also known as stress-induced cardiomyopathy or broken-heart syndrome, is defined as an abrupt onset of left ventricular dysfunction in response to severe emotional or... sidhant sibal father
Cardiotoxicity: Heart Damage from Cancer Treatment
WebCyclophosphamide and Cardiomyopathy - a phase IV clinical study of FDA data Summary: Cardiomyopathy is found among people who take Cyclophosphamide, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months. The phase IV clinical study analyzes which people take Cyclophosphamide and have … WebJul 14, 2014 · Cyclophosphamide-induced cardiotoxicity (CIC) is a well-known adverse effect and not that uncommon [ 1 ]. Symptoms occur usually within 1 to 3 weeks, and although in some patients cardiotoxicity resolves without late consequences, the mortality rate can be as high as 43% [ 2 – 4 ]. Drug side effects are usually seen after a single … WebJan 1, 2013 · Cyclophosphamide is increasingly used to treat various types of cancers and autoimmune conditions. Higher doses of this drug may produce significant cardiac toxicity, including fatal hemorrhagic myocarditis. In this review, we present a case of cyclophosphamide-induced cardiomyopathy requiring mecha … the pointsuites universal orlando